Reinforcing our hypothesis that FABP6 may be an interesting biomarker for colon cancer, in the same work Ohmachi et al.[23] found that tumours expressing higher levels of FABP6 were smaller, supporting that theory that FABP6 could be a biomarker for the early stage of carcinogenesis. This evidence concerns the gene FABP6 and colonic neoplasm.